Kenya vs Zambia: Population requiring preventive chemotherapy for schistosomiasis
Kenya
4.77 million
in 2024
Zambia
4.79 million
in 2024
Kenya rank
18th
Zambia rank
17th
Population requiring preventive chemotherapy for schistosomiasis over time
- Kenya
- Zambia
How they compare
Zambia currently reports 4.79 million against 4.77 million in Kenya, a difference of 26,540.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Kenya ahead.
Kenya ranks 18th and Zambia ranks 17th of 52 countries.
Across the 2 decades both report, Kenya averaged higher in 1 and Zambia in 1.
Head to head by decade
| Decade | Kenya | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.35 million | 4.65 million | 1.70 million | Kenya |
| 2020s | 4.24 million | 4.50 million | 262,428 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Kenya or Zambia?
- Zambia, at 4.79 million against 4.77 million in Kenya as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Kenya and Zambia?
- 26,540, with Zambia ahead.
- How many years of comparable data are there for Kenya and Zambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Kenya and Zambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Kenya ranks 18th and Zambia ranks 17th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.